Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

This study is currently recruiting participants.
Verified June 2013 by Massachusetts Eye and Ear Infirmary
Sponsor:
Collaborators:
Bascom Palmer Eye Institute
New York Presbyterian Hospital
Information provided by (Responsible Party):
Massachusetts Eye and Ear Infirmary
ClinicalTrials.gov Identifier:
NCT01072357
First received: February 18, 2010
Last updated: June 21, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)